Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Approves GSK's H5N1 Flu Vaccine | Contract Pharma

What are you searching for?

Sign in
Trials & Filings

FDA Approves GSK’s H5N1 Flu Vaccine

Will be added to the national stockpile

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The FDA has approved GlaxoSmithKline’s pandemic flu vaccine for use in the event of an H5N1 bird flu epidemic. The vaccine will be added to the national stockpile and will not be available for commercial use.

The vaccine is the first H5N1 vaccine to be approved in the U.S. to contain an adjuvant, or booster, that turbo-charges the body’s immune response to the vaccine. The vaccine is approved for use in people over the age of 18 who are at increased risk of exposure to the H5N1 flu virus.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters